Real-life Evaluation of the Safety and Performance of EUROTEKNIKA Dental Implants
1 other identifier
observational
868
1 country
1
Brief Summary
Real-life evaluation of the safety and performance of EUROTEKNIKA dental implants
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2022
CompletedStudy Start
First participant enrolled
March 25, 2022
CompletedFirst Posted
Study publicly available on registry
May 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2028
May 16, 2022
May 1, 2022
5.3 years
March 3, 2022
May 10, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
The success rate of tissue integration of the implant
Integration of the implant 5 years after implantation
5 years after implantation
Secondary Outcomes (7)
assessment of the quality of life of patients following the recovery of full dentition with the GOHAI score (General Oral Health Assessment Index)
5 years after implantation
Complication rate taking into account pain, local tenderness, infection, mobility of the implant, fracture
5 years after implantation
measuring chewing function after prosthesis placement
5 years after implantation
Rate of inflammation (visual)
5 years after implantation
Assessment of the evolution of the péri-implant tissues
5 years after implantation
- +2 more secondary outcomes
Study Arms (2)
prospective
A prospective cohort will be recruited into the study to meet the secondary objective of improving quality of life. In fact, to measure the improvement in quality of life, a questionnaire must be completed by the patient before the implant is placed. Answers to this questionnaire preoperatively cannot be collected for patients recruited retrospectively.
retrospective
Patients who received one or more EUROTEKNIKA implants before 2017 may be included in the study for the retrospective cohort
Interventions
an implant is surgically inserted into the maxilla or mandible, and then an abutment is connected to this implant to support the dental prosthesis.
Eligibility Criteria
Patients who received one or more EUROTEKNIKA implants before 2017 may be included in the study for the retrospective cohort for Naturactis, Naturall+, Aesthetica+2, ORIGIN, iBone E, iBone S and iBone G implants. These patients will be included consecutively in chronological order to avoid selection bias. A prospective cohort will also be recruited in the study, in order to meet the secondary objective concerning the improvement of the quality of life. In fact, to measure the improvement in quality of life, a questionnaire must be completed by the patient before the implant is placed. Answers to this questionnaire preoperatively cannot be collected for patients recruited retrospectively.
You may qualify if:
- Patient aged 18 or over
- Patient who has completed bone growth
- Patient informed and agreeing to participate in the study
- Partially or totally edentulous patient who will be implanted with the EUROTEKNIKA dental implant (for the prospective cohort)
- Patient to benefit from the placement of an implant for the creation of a single crown (for the prospective cohort)
- Patient implanted with the EUROTEKNIKA dental implant before 2017 (for the retrospective cohort)
- Patient having benefited from the placement of an implant for the creation of a single crown (for the retrospective cohort)
You may not qualify if:
- Pregnant or breastfeeding women (for the prospective cohort)
- Patient with bone disease in the cervico-facial region
- Patient refusing to participate in the study
- Patient with at least one contraindication to implantation (for the prospective cohort)
- Patient to benefit from the placement of an implant with immediate or early loading (for the prospective cohort)
- Patient to benefit from the placement of an implant for the support of the bridge, piles, attachment (for the prospective cohort)
- Patient having benefited from the placement of an implant with immediate or early loading (for the retrospective cohort)
- Patient having benefited from the placement of an implant for the support of the bridge, piles, attachment (for the retrospective cohort)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Euroteknikalead
- EVAMEDcollaborator
Study Sites (1)
Chu Clermont Ferrand
Clermont-Ferrand, 63003, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 3, 2022
First Posted
May 16, 2022
Study Start
March 25, 2022
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
February 1, 2028
Last Updated
May 16, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share